These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32663214)

  • 1. Cost-benefit Analysis of IUI and IVF based on willingness to pay approach; case study: Iran.
    Darvishi A; Goudarzi R; Zadeh VH; Barouni M
    PLoS One; 2020; 15(7):e0231584. PubMed ID: 32663214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
    Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
    Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis.
    Goverde AJ; McDonnell J; Vermeiden JP; Schats R; Rutten FF; Schoemaker J
    Lancet; 2000 Jan; 355(9197):13-8. PubMed ID: 10615885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility.
    Pashayan N; Lyratzopoulos G; Mathur R
    BMC Health Serv Res; 2006 Jun; 6():80. PubMed ID: 16796733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial of intra-uterine insemination versus in vitro fertilisation in patients with idiopathic or mild male infertility.
    Elzeiny H; Garrett C; Toledo M; Stern K; McBain J; Baker HW
    Aust N Z J Obstet Gynaecol; 2014 Apr; 54(2):156-61. PubMed ID: 24579923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles.
    Bahadur G; Homburg R; Bosmans JE; Huirne JAF; Hinstridge P; Jayaprakasan K; Racich P; Alam R; Karapanos I; Illahibuccus A; Al-Habib A; Jauniaux E
    BMJ Open; 2020 Mar; 10(3):e034566. PubMed ID: 32184314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis.
    Bordewijk EM; Weiss NS; Nahuis MJ; Bayram N; van Hooff MHA; Boks DES; Perquin DAM; Janssen CAH; van Golde RJT; Lambalk CB; Goddijn M; Hompes PG; van der Veen F; Mol BWJ; van Wely M;
    Hum Reprod; 2019 Feb; 34(2):276-284. PubMed ID: 30576539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IVF with planned single-embryo transfer versus IUI with ovarian stimulation in couples with unexplained subfertility: an economic analysis.
    van Rumste MM; Custers IM; van Wely M; Koks CA; van Weering HG; Beckers NG; Scheffer GJ; Broekmans FJ; Hompes PG; Mochtar MH; van der Veen F; Mol BW
    Reprod Biomed Online; 2014 Mar; 28(3):336-42. PubMed ID: 24456703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growing body of evidence supports intrauterine insemination as first line treatment and rejects unfounded concerns about its efficacy, risks and cost effectiveness.
    Bahadur G; Homburg R
    JBRA Assist Reprod; 2019 Jan; 23(1):62-67. PubMed ID: 30277707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline adherence is worth the effort: a cost-effectiveness analysis in intrauterine insemination care.
    Haagen EC; Nelen WL; Adang EM; Grol RP; Hermens RP; Kremer JA
    Hum Reprod; 2013 Feb; 28(2):357-66. PubMed ID: 23202990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation.
    Neumann PJ; Johannesson M
    Med Care; 1994 Jul; 32(7):686-99. PubMed ID: 8028404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and Validity of the Contingent Valuation Method for Estimating Willingness to Pay: A Case of In Vitro Fertilisation.
    Settumba SN; Shanahan M; Botha W; Ramli MZ; Chambers GM
    Appl Health Econ Health Policy; 2019 Feb; 17(1):103-110. PubMed ID: 30315488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro fertilisation for unexplained subfertility.
    Pandian Z; Bhattacharya S; Vale L; Templeton A
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003357. PubMed ID: 15846658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro fertilisation for unexplained subfertility.
    Pandian Z; Bhattacharya S; Nikolaou D; Vale L; Templeton A
    Cochrane Database Syst Rev; 2002; (2):CD003357. PubMed ID: 12076476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Couples' willingness to pay for IVF/ET.
    Granberg M; Wikland M; Nilsson L; Hamberger L
    Acta Obstet Gynecol Scand; 1995 Mar; 74(3):199-202. PubMed ID: 7900524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization.
    Van Voorhis BJ; Barnett M; Sparks AE; Syrop CH; Rosenthal G; Dawson J
    Fertil Steril; 2001 Apr; 75(4):661-8. PubMed ID: 11287015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of male infertility due to sperm surface antibodies: IUI or IVF?
    Ombelet W; Vandeput H; Janssen M; Cox A; Vossen C; Pollet H; Steeno O; Bosmans E
    Hum Reprod; 1997 Jun; 12(6):1165-70. PubMed ID: 9221994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro fertilisation for unexplained subfertility.
    Pandian Z; Gibreel A; Bhattacharya S
    Cochrane Database Syst Rev; 2012 Apr; (4):CD003357. PubMed ID: 22513911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Benefit Analysis of Hysteroscopic Polypectomy Before Controlled Ovarian Hyperstimulation and Intrauterine Insemination in Infertile Women.
    Sundheimer LW; Kathiresan A; Dumesic D; Parvataneni R; Shamonki M
    J Reprod Med; 2017; 62(3-4):127-32. PubMed ID: 30230303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IVF or IUI as first-line treatment in unexplained subfertility: the conundrum of treatment selection markers.
    Tjon-Kon-Fat RI; Tajik P; Zafarmand MH; Bensdorp AJ; Bossuyt PMM; Oosterhuis GJE; van Golde R; Repping S; Lambers MDA; Slappendel E; Perquin D; Pelinck MJ; Gianotten J; Maas JWM; Eijkemans MJC; van der Veen F; Mol BW; van Wely M;
    Hum Reprod; 2017 May; 32(5):1028-1032. PubMed ID: 28333222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.